Compare drug alternatives

Vyepti® Alternatives

Vyepti®

(eptinezumab-jjmr)
Vyepti
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat. Vyepti is FDA approved for the following indications: Migraine prevention.

Ubrelvy®

(ubrogepant)
Ubrelvy
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines. Ubrelvy is FDA approved for the following indications: Migraine.

Dosage & Administration

Administration
Intravenous infusion (must be diluted)
Oral
Dosing
100 mg every 3 months or 300 mg (for some patients)
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
Latin Shorthand
100 mg q3mo
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.

Financial Assistance

Copay
$0
$0
Annual Cap
$200 per infusion for administration costs
Maximum savings of $50 per pill for up to 13 prescription fills.
Assistance Expiration
Calendar year
13 prescription fills
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Vyepti
Ubrelvy